Omaxe Subsidiaries Gain RERA Approval for UP Commercial Projects

Omaxe Garv Buildtech Private Limited, a wholly-owned subsidiary of Omaxe Limited, has secured RERA registration certificates for two commercial projects in Uttar Pradesh. The registrations, effective from May 7, 2026, are valid until December 17, 2030, clearing the way for the company to begin sales.

Regulatory Filing Confirms Project Approvals

A recent BSE filing confirmed that Omaxe Garv Buildtech Private Limited received RERA registration certificates for two commercial projects in Uttar Pradesh. The projects are scheduled to launch on May 7, 2026, with registrations valid until December 17, 2030. This regulatory approval legally permits the sale, transfer, and advertisement of project units, allowing for the immediate start of sales operations.

Why This Matters

Securing RERA registration is a fundamental step for real estate developers, enhancing project credibility and buyer confidence. It confirms compliance with regulatory standards and offers assurance for timely project delivery. For Omaxe, these approvals are anticipated to bolster its brand value, speed up sales for the Uttar Pradesh projects, and positively impact its consolidated financial results.

Omaxe's Previous Projects in Uttar Pradesh

Omaxe Limited is an established Indian real estate developer with a diverse portfolio spanning residential, commercial, and retail projects. The company has a history of development in Uttar Pradesh. In March 2026, Omaxe subsidiaries previously obtained RERA registrations for residential projects in Uttar Pradesh and Punjab. Before that, in October 2025, Omaxe Garv Buildtech received RERA approval for its residential project 'The Nest' in Lucknow. The company had also announced plans to invest over ₹250 crore in a premium housing project, 'Omaxe Cassia', at its Omaxe Metro City township in Lucknow.

Impact of New Approvals

• Sales Start: The subsidiary can now officially market and sell units in the two registered commercial projects.
• Buyer Trust: RERA approval signifies regulatory compliance, building trust with potential buyers.
• Financial Contribution: Successful sales and project execution are expected to positively impact Omaxe's consolidated financial results.
• Regulatory Alignment: The company demonstrates adherence to key real estate sector regulations.

Risks to Watch

The RERA registrations are granted with standard conditions that the subsidiary must continuously meet. Failure to comply with these ongoing requirements, especially regarding project timelines and quality standards, could present regulatory challenges.

Peer Comparison

Omaxe operates in a competitive real estate market alongside major developers like DLF Limited, Godrej Properties Limited, and Sobha Limited. DLF, India's largest developer, reported Q2 FY26 income of Rs. 2,261 crore. Sobha Limited achieved a consolidated revenue of ₹4,163 crore in FY 2024-25. Godrej Properties' trailing 12-month revenue was $421M as of December 31, 2025. While Omaxe's recent financial performance has been challenging, securing RERA approvals for new projects is a step towards revenue generation, a critical factor for all players in the sector.

Regulatory History

Omaxe Limited has faced regulatory scrutiny, including a two-year SEBI ban and a ₹47 lakh fine in July 2024 for financial irregularities between FY19-FY21.

Future Monitoring

• Monitor sales performance and booking figures for the newly registered commercial projects.
• Observe Omaxe's execution progress and adherence to RERA timelines for project delivery.
• Track announcements regarding the resolution of past regulatory issues and their impact.
• Analyze Omaxe's overall financial health, debt management, and profitability in subsequent quarters.